Fulgent Genetics (FLGT) Other Non-Current Liabilities (2016 - 2026)

Fulgent Genetics (FLGT) has 10 years of Other Non-Current Liabilities data on file, last reported at $9.4 million in Q1 2026.

• Quarterly Other Non-Current Liabilities rose 53.09% year-over-year to $9.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.4 million (up 53.09% YoY) and the FY2025 annual result came in at $7.6 million, up 2017.78% from the prior year.
• Other Non-Current Liabilities climbed to $9.4 million in Q1 2026 per FLGT's latest filing, from $7.6 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $20.0 million in Q3 2022, with the low at $182000.0 in Q2 2025.
• Average Other Non-Current Liabilities over 5 years is $8.3 million, with a median of $6.3 million recorded in 2024.
• Year-over-year, Other Non-Current Liabilities soared 2415.17% in 2022 and slumped 96.17% in 2025.
• Fulgent Genetics' Other Non-Current Liabilities stood at $18.2 million in 2022, then tumbled by 67.22% to $6.0 million in 2023, then slumped by 93.98% to $360000.0 in 2024, then surged by 2017.78% to $7.6 million in 2025, then grew by 22.93% to $9.4 million in 2026.
• Business Quant data shows FLGT's Other Non-Current Liabilities at $9.4 million in Q1 2026, $7.6 million in Q4 2025, and $2.0 million in Q3 2025.